Long-term opioid contract use for chronic pain management in primary care practice. A five year experience.

1: J Gen Intern Med. 2007 Apr;22(4):485-90.

Hariharan J, Lamb GC, Neuner JM.
Division of General Internal Medicine, Medical College of Wisconsin, Froedtert East Clinic Bldg., Suite E4200, 9200 West Wisconsin Avenue, Milwaukee, WI, 53226, USA, jharihar@mcw.edu.

BACKGROUND: The use of opioid medications to manage chronic pain is complex and challenging, especially in primary care settings. Medication contracts are increasingly being used to monitor patient adherence, but little is known about the long-term outcomes of such contracts. OBJECTIVE: To describe the long-term outcomes of a medication contract agreement for patients receiving opioid medications in a primary care setting. DESIGN: Retrospective cohort study. SUBJECTS: All patients placed on a contract for opioid medication between 1998 and 2003 in an academic General Internal Medicine teaching clinic. MEASUREMENTS: Demographics, diagnoses, opiates prescribed, urine drug screens, and reasons for contract cancellation were recorded. The association of physician contract cancellation with patient factors and medication types were examined using the Chi-square test and multivariate logistic regression. RESULTS: A total of 330 patients constituting 4% of the clinic population were placed on contracts during the study period. Seventy percent were on indigent care programs. The majority had low back pain (38%) or fibromyalgia (23%). Contracts were discontinued in 37%. Only 17% were cancelled for substance abuse and noncompliance. Twenty percent discontinued contract voluntarily. Urine toxicology screens were obtained in 42% of patients of whom 38% were positive for illicit substances. CONCLUSIONS: Over 60% of patients adhered to the contract agreement for opioids with a median follow-up of 22.5 months. Our experience provides insight into establishing a systematic approach to opioid administration and monitoring in primary care practices. A more structured drug testing strategy is needed to identify nonadherent patients.

PMID: 17372797 [PubMed – in process]

FMS Global News


About FMS Global News

Folllowing Rick Usher's death in December 2008, at his request in September of that year, I had agreed, as his principal contributor and an experienced journalist, to run the FMS Global News service due to his heavy commitments to music and raising research funds through this avenue. Following his sad and sudden death I hope to continue his work as he would have wished.
This entry was posted in Awareness, Back Pain, Chronic Fatigue, Chronic Fatigue Syndrome, Chronic Insomnia, Chronic Myofacial Pain, Chronic Pain, Clinical, Fibrohugs, Fibromyalgia, Fibromyalgia News, FMS Global News, Global News, Health, Health Insurance, Invisible Illness, Medical, Medical Insurance, Medical Journals, Myofacial Pain Syndrome, Narcotics, News, News Australia, News Canada, News India, News Ireland, News Norway, News Scotland, News UK, Pain, Pain Management, Pain Management Clinic, Palliative Care, Research, RSS, Sleep Disorders, Tenderpoints, Universities, US, World, World News, Worldwide. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s